3 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow J2H Biotech: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2a Study to Evaluate Safety and Explore Efficacy of J2H-1702 for NASH J2H-1702, Placebo - Non-alcoholic Steatohepatitis | Phase 2 | Completed | J2H Biotech | 87 | 2023-02-15 | 2026-07-30 |
| Investigate Safety, Tolerability, PK/PD of J2H-1702 in Healthy Females Amg dose administration group, Amg dose administration group- Placebo, Bmg dose administration group - Non-alcoholic Steatohepatitis | Phase 1 | Completed | J2H Biotech | 16 | 2023-01-02 | 2025-12-17 |
| Investigate Safety, Tolerability, PK/PK of J2H 1702 in Healthy Males Single administration Amg dose Group, Single administration Bmg dose Group, Single administration Cmg dose Group - Non-alcoholic Steatohepatitis | Phase 1 | Completed | J2H Biotech | 100 | 2020-08-12 | 2025-12-17 |
Non-alcoholic Fatty Liver Disease (3)
South Korea (3)